Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment
2018
Purpose
Local ablative treatment to oligometastatic patients can result in long-term disease-free survival in some cancer patients. The importance of this treatment paradigm in prostate cancer is a rapidly evolving field. Herein, we report on the safety and preliminary clinical outcomes of a modern cohort of oligometastatic prostate cancer (OPC) patients treated with consolidative stereotactic ablative radiation (SABR).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
35
References
15
Citations
NaN
KQI